Abstract:BACKGROUND. Second primary tumors (SPTs) have a substantial impact on survival in cancer patients. However, risk factors for SPTs have not been documented well, especially in nasopharyngeal carcinoma (NPC). The objective of this retrospective analysis was to evaluate such risks in patients with NPC after they received definitive radiation treatment.METHODS. Three hundred twenty-six consecutive patients with pathologically confirmed, nonmetastatic, undifferentiated NPC who received treatment between January 1, 1994 and December 30, 1995 were analyzed. All patients were restaged in accordance with the 2002 American Joint Committee on Cancer staging classification. There were 18 patients (5.5%) with Stage I NPC, 152 patients (46.6%) with Stage II NPC, 101 patients (31.0%) with Stage III NPC, and 55 patients (16.9%) with Stage IVA or IVB NPC at initial diagnosis. All patients received definitive radiotherapy with either Cobalt-60 or megavoltage therapy. High-dose-rate brachytherapy was given to 23 patients either as part of their primary treatment or as adjuvant treatment for residual lesions.RESULTS. The median follow-up for all patients was 5.6 years (range, 1.0-8.0 years). Seventeen patients (5.2%) developed SPTs, for an average annual rate of 1.0%, and the 5-year cumulative incidence was 5.8%. Six SPTs were located within the radiation field. The cumulative incidence of in-field SPTs was 0.35% at 3 years and 1.2% at 5 years, and the average annual rate was 0.35%. Eleven patients (64.7%) had tumors of the upper aerodigestive tract (UADT). Among the 14 SPTs that occurred within 5 years after radiotherapy, only 3 tumors (21.4%) occurred within the radiation field. In contrast, all 3 SPTs that occurred > 5 years after radiotherapy occurred within the radiation field (P = .029). Multivariate analysis showed that age was the only independent risk factor for developing SPTs after RT for NPC. Advanced age (age >= 50 years) was associated with a 37% increased risk of developing SPTs (relative risk, 1.367; 95% confidence interval, 1.067-1.1753; P = .014). Other factors, including gender, tumor or lymph node classification, chemotherapy, total radiation dose to the nasopharynx, reirradiation, and adjuvant brachytherapy did not influence the risk of SPTs.CONCLUSIONS. SPTs in patients with NPC occurred preferentially in the UADT and tended to develop within the irradiated field > 5 years after patients received radiation. Older patients with NPC (age >= 50 years) may be at increased risk. Further studies with larger samples and longer follow-up will be needed to confirm these findings.

Risk of Stroke in Nasopharyngeal Cancer Survivors

The Global Burden of Nasopharyngeal Carcinoma from 2009 to 2019: an Observational Study Based on the Global Burden of Disease Study 2019.

Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA.

Vertebral artery stenosis predicts cerebrovascular diseases following radiotherapy for nasopharyngeal carcinoma

Effect of Patient-related Delay in Diagnosis on the Extent of Disease and Prognosis in Nasopharyngeal Carcinoma

Stroke Risks in Survivors of Head and Neck Cancer

The Risk of Second Primary Tumors in Patients with Nasopharyngeal Carcinoma after Definitive Radiotherapy

Characteristics of Early Death in Patients with Localized Nasopharyngeal Cancer: A Population-Based SEER Analysis

Causes of Death in Long-Term Nasopharyngeal Carcinoma Survivors

A National Study of Survival Trends and Conditional Survival in Nasopharyngeal Carcinoma: Analysis of the National Population-Based Surveillance Epidemiology and End Results Registry

Length and location of post-PIRCS predict percutaneous transluminal angioplasty and stenting-related restenosis in nasopharyngeal cancer

Clinical and MRI risk factors predicting post-irradiation carotid blowout syndrome in patients with nasopharyngeal cancer

Clinicopathological factors affecting the prognosis of massive hemorrhage after radiotherapy for patients having nasopharyngeal carcinoma

Prognostic value of hypertension in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy

A Clinical Series in Patients with Naso-Pharyngeal Cancer and Their Outcomes with Stent Graft Treatment for Sentinel Bleeding to Prevent Frank Carotid Rupture

Prevalence of cancer-related cognitive impairment among patients with nasopharyngeal carcinoma: a cross-sectional study

Analysis of the risk factors of the radiation-induced encephalopathy in nasopharyngeal carcinoma: A retrospective cohort study

Middle Cerebral Artery Stenosis in Patients with Nasopharyngeal Carcinoma after Radiotherapy: the Incidence of Stenosis and the Risk Factors

Impact of Prior Cancer on Outcomes in Nasopharyngeal Carcinoma.

Impact of smoking on survival in nasopharyngeal carcinoma: A cohort study with 23,325 patients diagnosed from 1990 to 2016

Suggestions for Surveillance and Radiation Strategy in Nasopharyngeal Carcinoma Treated with IMRT: Based on Hazard-Rate and Patterns of Recurrence.